Clinical Trials Browser

Purpura, Thrombocytopenic, Idiopathic × Clear all

Neoplasms, Purpura, Thrombocytopenic, Idiopathic

NCT06873672 2025-03-13

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

Not yet recruiting

360 enrolled

CNSGenitourinary

Wilms Tumor, Neuroblastoma, Purpura, Thrombocytopenic, Idiopathic

NCT02077192 2023-12-11

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Phase 3 Completed

123 enrolled 11 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT05393999 2023-04-24

SABRE

Phase 2 Withdrawn

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Purpura, Thrombotic Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic, Neoplasms, Plasma Cell

NCT01957176 2022-12-30

A Rollover Study to Provide Continued Treatment With Eltrombopag

Phase 4 Completed

22 enrolled 9 charts

Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myeloid, Acute, Purpura, Thrombocytopenic, Idiopathic

NCT05328804 2022-04-26

Herombopag + rhTPO in Severe Immune Thrombocytopenia

Phase 3 Unknown

90 enrolled

Lymphoid

Lymphoma, Follicular, Purpura, Thrombocytopenic, Idiopathic

NCT02076399 2019-02-12

FIT

Phase 3 Completed

76 enrolled 17 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT02076412 2019-01-25

FIT

Phase 3 Completed

74 enrolled 17 charts 1 FDA

Purpura, Thrombocytopenic, Idiopathic

NCT01610180 2018-07-16

Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

Phase 2 Completed

18 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Purpura, Thrombocytopenic, Idiopathic

NCT01444417 2017-02-09

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Phase 3 Completed

62 enrolled 16 charts 1 FDA

Classical hematology

Purpura, Thrombocytopenic, Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic

NCT00515203 2014-07-25

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects

Phase 1/2 Completed

22 enrolled 13 charts 1 FDA

Purpura, Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic

Clinical Trials

MATAC

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

SABRE

A Rollover Study to Provide Continued Treatment With Eltrombopag

Herombopag + rhTPO in Severe Immune Thrombocytopenia

FIT

FIT

Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects